|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2019
vol. 121 abstract:
Case report
Rheumatoid arthritis-associated uveitis treated with adalimumab
Elżbieta Kalaczyńska
1
,
Ewa Bilińska
1
,
Marta Owidzka
1
,
Wojciech Omulecki
1
Online publish date: 2019/09/23
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Uveitis is an inflammatory ocular disorder of various aetiology affecting the middle vascular layer of the eye. The condition mainly affects relatively young patients and if untreated, it can lead to significant complications, including blindness. Hence, it is of a critical importance to prevent inflammation and vision loss in eyes with uveitis.
Here, we report a case of a 36-year-old male with a history of rheumatoid arthritis, who was first diagnosed with anterior uveitis, and subsequently presented with macular oedema and epiretinal membranes. However, conventional treatment with a steroid was not sufficient to control the inflammation and was associated with elevated intraocular pressure as a side effect. Eventually, the patient was treated with adalimumab, which effectively prevented disease progression and resolved his rheumatoid symptoms. keywords:
uveitis, adalimumab, rheumatoid arthritis, macular oedema, epiretinal membrane |
|
POLSKI
